The poxvirus molluscum contagiosum (MC) has a worldwide distribution and its prevalence is on the rise. Here we report that the MCV MC013L protein inhibits glucocorticoid and vitamin D, but not retinoid or estrogen, nuclear receptor transactivation. A direct interaction of MC013L with glucocorticoid and vitamin D receptor is supported by yeast two-hybrid, GST pull-down, and far Western blot analyses. Glucocorticoids act as potent inhibitors of keratinocyte proliferation, while vitamin D and retinoids promote and block terminal differentiation, respectively. Therefore, MC013L may promote efficient virus replication by blocking the differentiation of infected keratinocytes. MC013L may be the first member of a new class of poxvirus proteins that directly modulate nuclear receptor-mediated transcription.
Introduction. With the extinction of variola virus, poxvirus molluscun contagiosum (MCV) is the only poxvirus circulating in the human population. Molluscum contagiosum presents as small clusters of epidermal, fleshcolored, raised nodules of 2-5 mm in diameter in immunocompetent individuals (1) . The lesions are generally painless, appearing on the trunk and limbs (except palms and soles). The disease can be fairly common in children and sexually transmitted in teenagers and adults. Lesions can persist for as little as 2 weeks or as long as 2 years and spontaneously resolve. Reinfections can be common, suggesting that the virus, or its site of replication, does not induce an effective immune response. MCV is an opportunistic infection of immunocompromised individuals and is considered a cutaneous marker of severe immunodeficiency in HIV-infected patients, especially those with severely depressed CD4 ϩ T cell numbers. The prevalence of MCV in human populations is on the rise.
The inability to replicate MCV in cell culture has hampered its molecular biological characterization until now. DNA sequence analysis of the MCV type 1 genome (190 kb) has revealed promoters, transcription termination signals, and DNA concatemer resolution sequences which are highly homologous to those of orthopoxviruses (OPV) such as vaccinia virus (VV) (2, 3) . Further analysis of the entire protein coding sequence has allowed the identification of 182 open reading frames (ORFs). One hundred five ORFs have direct counterparts in OPV and are located mainly in the central portion of the genome, encoding functions essential for the production of progeny virions. The remaining 77 ORFs are without OPV counterparts and are mainly located in the terminal regions of the MCV genome, which by analogy to the OPV should contain the hrm (host response modifier) genes. These genes target the multifactorial responses to infection, host cell macromolecular synthetic processes, and apoptotic mechanisms. Because MCV replicates only in human keratinocytes of the epidermis, it is probable that the putative MCV hrm genes will have evolved to modulate the skin immune system and keratinocyte homeostasis. Gene products have been shown to inhibit chemokine action (MC148R) (4, 5) and apoptosis (MC159L and MC160L) (6, 7) and to scavenger reactive oxygen metabolites (MC066L) (8) . Recently, ORFs MC051L, MC053L, and MC054L were shown to have homology with a family of IL-18 binding proteins (9, 10) , and the latter two were also shown to bind IL-18 (11) . In this report we have investigated the function of the putative hrm MC013L.
Results. Similarity searches of the nonredundant protein database and the expressed sequence tag database with MC013L nucleotide sequences revealed significant homology only to the DnaJ family of molecular chaper-ones ( Fig. 1) (2, 3) . Members of this family regulate protein folding, assembly, and transport in both eukaryotic and prokaryotic systems (12, 13) . There are two regions of significant homology to the DnaJ protein family. First, MC013L residues 1 to 64 show homology with J-domains, which contain the canonical HPD motif that defines the DnaJ family. This MCV J-domain, however, could not substitute functionally for the J-domain of the Escherichia coli DnaJ protein in chimeric proteins in vivo (data not shown). The second homologous region (residues 116 to 157) of MC013L corresponds to an area of DnaJ proteins of unknown function. In DnaJ, this region falls between glycine/phenylalanine-rich and cysteinerich regions, which are highly conserved among DnaJ family members but are not present in the MC013L protein. Within this second region, MC013L displays a LXXLL motif, which has been shown to be necessary and sufficient for mediating binding of some transcriptional coactivators such as RIP-140, SRC-1, and CBP to various liganded nuclear receptors (14) . There does not appear to be any other significant homology between MC013L and these transcriptional coactivators. The possibility of a role for MC013L in modulating host cell transcriptional machinery gained additional weight with the observed localization of MC013L to the nucleus following transient expression in COS-7 cells (Fig. 2) . , and its cellular actions are mediated through the vitamin D nuclear receptor (VDR). We tested the MC013L protein in a COS-7 transient expression system for its ability to modulate vitamin D-mediated transactivation (Fig. 3A) . Expression of MC013L resulted in the dose-dependent inhibition of 1,25-(OH) 2 D 3 /VDRdependent transactivation of a growth hormone (GH) reporter construct by more than 70% compared to similar transfections with an expression vector carrying MC013L in an antisense orientation (Fig. 3A) . Western blot analysis verified that the MC013L inhibitory effect was not mediated through reduced synthesis of VDR. In an effort to define the specificity of MC013L inhibition, other members of the nuclear receptor superfamily were cotransfected into COS-7 cells with pMT3A-MC013L (Fig. 3B) . Inhibition was observed against ligand-mediated glucocorticoid receptor (GR)-dependent, but not retinoid acid receptor (RAR)-dependent, transactivation. In this experiment, MC013L showed a modest inhibition of estrogen receptor (ER)-dependent transactivation with a 7.5-fold increase in GH synthesis in the presence of ligand and MC013L versus a 13-fold increase in a control reaction. In two other experiments, however, MC013L inhibition of ER-dependent transactivation was not statistically significant [27-and 30-fold (Experiment 2) and 31-and 16-fold (Experiment 3) increases in GH synthesis in the presence and absence of MC013L, respectively]. Furthermore, expression of MC013L did not significantly alter the expression of general promoter constructs, such as TK-GH and RSV-GH, under similar transfection conditions (data not shown). Taken together, these studies are consistent with the MC013L protein exerting a selective inhibitory effect on VDR-and GR-mediated transcription. To determine if the MC013L LETLL sequence was important in the inhibition of VDR/GR transactivation, we used in vitro mutagenesis methods to create site-specific mutations in this region. The LETLL sequence was mutated by the substitution of alanine for leucine residues (Fig. 3C ). The L122A, L126A, and L125/ 126A mutations resulted in a diminution of the inhibition of both VDR-and GR-dependent transactivation by MC013L; however, the L125A mutation had no effect. This result was in contrast to the absolute requirement for the LXXLL motif in the interaction of RIP-140, SCR-1, and CBP with tested liganded nuclear receptors (14) .
MC013L Directly Interacts with VDR and GR Nuclear
Receptors. Direct MC013L interactions with VDR and GR were examined in vivo using yeast two-hybrid systems and in vitro with glutathione S-transferase (GST) pulldown and far Western blot assays. The MC013L gene was expressed as a fusion protein with the activation domain of Gal4 and tested for interaction with the ligandbinding domains of VDR, GR, ER, and RAR, which were fused to the DNA-binding domain of Gal4. Interaction (as indicated by growth on histidine-deficient plates) was observed between MC013L and VDR, but not with RAR, GR, or ER (data not shown). As expected, the MC013L fusion protein did not interact with bait constructs of unrelated proteins p53, snf4, and G␣. A more sensitive and quantitative measurement of interaction in this system is the liquid ␤-galactosidase assay, which clearly demonstrated a strong MC013L interaction with the li- gand-binding domain of VDR in the presence and absence of ligand (Fig. 4A) . The presence of ligand increased the interaction of MC013L with VDR 1.6-fold compared to a 3.2-fold increase noted for VDR interaction with its heterodimeric partner, RXR (Experiment 2). Interestingly, none of the LETLL mutations prevented MC013L interaction with VDR. In fact, the L126A and L125/126A mutations appeared to enhance the interaction, even though they were associated with a modest inhibition of MC013L function in the VDR/GR transactivation assay. Again, no interaction could be demonstrated between MC013L and GR, ER, or RAR, yet these receptor fusions all interacted with the positive control GRIP. Because MC013L failed to inhibit ER or RAR transactivation, we had not expected to see interaction in the yeast two-hybrid assay; however, with GR this was not the case. We also attempted to demonstrate GR interaction with MC013L in the more sensitive LexA yeast two-hybrid system and through reversal of the fusion partners (data not shown). Still no interaction could be demonstrated.
Since the failure to demonstrate an interaction of GR with MC013L may be a property of this assay system, we tested for interaction in the GST pull-down and the far Western blot assays. In the GST pull-down assay, radiolabeled MC013L WT protein interacted with VDR and GR, but not with GST alone or GST-ER in the absence of ligand (Figs. 4B and 4C ). GST-ER was functional as it interacted with NCoA-62 (data not shown) (16) . The interaction of GR with MC013L appeared to be ϳ4-fold weaker than that with VDR. VDR interacted with L122A and L126A mutants as efficiently as with WT MC013L, but less so than with L125A and L125/126A mutants. GR had a similar relative range of interactions with the LETLL mutants, except for the L125A mutant, with which there was only a background level of interaction. All interactions were increased in the presence of the appropriate ligand (data not shown). Far Western blot analyses demonstrated a direct interaction of WT and L125/126A MC013L with VDR and GR, but not with ER (Fig. 4D) . Taken together the above findings are consistent with a ligand independent, direct interaction between MC013L and VDR or GR that does not require an intact LETLL sequence.
Expression of MC013L during MCV Natural Replication Cycle. Histopathological observations and in situ [
3 H]thymidine labeling of lesions suggest that MCV replicates during the 9 to 15 days it takes the infected keratinocyte to reach the stratum granulosum, with virus specific changes detectable initially in the lower layers of the stratum spinosum (several cells distal to the basement membrane) (17) (18) (19) (20) . To identify the virus-infected cells expressing MC013L, molluscum contagiosum lesions were analyzed by immunocytochemistry. The light-level photograph displayed in Fig. 5 reveals the presence of MC013L protein in patches of keratinocytes in the lower layers of the stratum spinosum proximal to the basal layer. The loss of MC013L staining from the keratinocyte as it migrates through the epidermis may be explained by degradation of the protein or by masking by cellular or viral proteins.
Discussion. Taken together, these findings indicate that the MC013L protein inhibits VDR and GR transactivation of a reporter gene construct and that the inhibition is most likely mediated through direct interaction with the nuclear receptor. The presence of an LXXLL motif and a DnaJ domain in the MC013L protein suggested possible mechanisms of interaction with VDR and GR, which were tested. For example, the DnaJ domain of MC013L could interfere with the conversion of GR from a non-steroid-binding to a steroid-binding form by competing with hsp40 (DnaJ homolog) in assembly of the hsp90, the hsp70, and the GR ternary complex (21, 22) . Since J-domain interactions with hsp70 have been shown to be dependent on the HPD motif (13, 23), we tested this possibility by introducing H30Q or D32N mutations into MC013L and by testing the mutants in the GR transactivation assay. The MC013L HPD mutants were as active as the WT protein in this assay (data not shown). Another possible mechanism of action could involve the binding of MC013L to the nuclear receptor's AF-2 domain through its LXXLL motif, thereby blocking access of the cotranscriptional activators. This simple competition model was ruled out by the analysis of a series of mutations in the LETLL sequence of MC013L. Except for the L125A mutation, mutations in the LETLL sequence did not prevent MC013L's interaction with VDR or GR as measured in yeast two-hybrid, GST pull-down, and far Western blot assays. Furthermore, inhibition by MC013L of VDR or GR transactivation assays in COS-7 cells was reversed only modestly by the LETLL mutations, except for the L125A mutant, which had no effect. In comparison, these same mutations in LXXLL motifs totally abolished the interaction of cotranscriptional activators RIP-140, SRC-1, and CBP with ER and RAR (14) . Also, if MC013L's inhibition of VDR and GR were mediated through the LXXLL motif, we would have expected ER and RAR transactivations to be similarly inhibited by MC013L, but they were not. Finally, MC013L interacts with VDR and GR in the absence of ligand, whereas the LXXLL-mediated interaction of cotranscriptional activators and nuclear receptors is ligand dependent. Taken together, these observations argue that MC013L inhibition of VDR and GR transactivation is not mediated through the regulatory mechanisms dependent on intact HPD or LXXLL motifs.
Keratinocyte homeostasis is dependent to a large extent on the fine-tuned interaction of epidermal growth factor and keratinocyte growth factor and on a number of hormones (estrogen, glucocorticoids, retinoids, and vitamin D) in the presence of calcium, which ultimately regulates the balance between cell proliferation, cell differentiation, and apoptosis. MC013L may help to optimize virus replication by maintaining keratinocytes in a proliferating state through blocking of the positive signals for differentiation induced by transactivation of nuclear receptors such as VDR and GR, but leaving unaffected retinoid-stimulated gene expression (Fig. 6) . Retinoids block terminal differentiation of keratinocytes and antagonize the prodifferentiation actions of 1,25(OH) 2 D 3 (15) . This possible role of MC013L would require the keratinocyte to be infected prior to irreversible progression into the differentiation pathway and would make the keratinocyte stem and transit amplifying cells the likely targets of a productive MCV infection. The stem cells divide infrequently but have the ability to regenerate the epidermis, whereas the transit amplifying cells are derived from stem cells and have a limited self-renewal capacity of about three rounds of division (24) . Both stem cells and transit amplifying cells are found in the epidemis as patches of ␤ 1 -integrin bright and dull cells, respectively. A similar patched distribution of MC013L-positive cells was observed in sections from molluscum lesions and may indicate that either MCV-infected stem cells or transit amplifying cells express MC013L, but not both. This issue is currently under investigation.
The study of MCV functions that modulate host processes should provide insights into the biology of the keratinocyte. In this study, we have shown that MC013L selectively inhibits transactivation by VDR and GR. To our knowledge, this is the first study describing the direct, but selective, interaction of a virus-encoded protein with members of the nuclear receptor family and inhibition of Keratinocytes in or proximal to the basal layer of the epidermis are infected with MCV through minor abrasions in the skin. As the infected cells migrate toward the surface of the epidermis over a period of 9-15 days, MCV sequentially expresses its genes, replicates genomic DNA, and assembles progeny virions, which ultimately fill greatly enlarged keratinocytes. These virus-filled structures are known as molluscum bodies and are pathognomonic for the disease (1, 33) . The basal layer of the epidermis is indicated with arrowheads. Patches of MC013L antigen-positive cells (brown) are indicated by arrows. The top left corner depicts the central core of the lesion, which opens to the surface of the epidermis. A similar staining pattern was observed with sections from two other MCV lesions (data not shown). Preimmune rabbit sera were nonreactive with consecutive tissue sections (data not shown). their transactivation. Perhaps MC013L modulates a novel nuclear receptor regulatory pathway important in the regulation of keratinocyte proliferation and differentiation. If so, the MC013L protein may have a host homolog, as do a number of viral proteins that appear to have been "pirated" from the host and modulate inflammatory, immune, and apoptotic processes (25) .
Materials and Methods. Multiple alignments.
The multiple alignments were manually created and edited with SeqVu (Garvan Institute for Medical Research, Sydney, NSW, Australia). Swiss Protein Accession Nos. MCV, P31689; coxiella burnetii, P42381; Human, P31689; E. coli, P08622, and streptomyces coelicolor, P40170. Selected gaps were introduced into the MC013L sequence to maximize matches.
Expression Plasmids and Reporter Constructs.
The MC013L open reading frame was amplified by PCR from MCV genomic DNA using specific primers containing restriction endonuclease recognition sites (5Ј primer: 5Ј-GCGGAATTCGACCATGGATCCGCATGAAGTTCTC-3Ј; 3Ј primer: 5Ј-GCGGAATTCAAG CTTATAGCTTTGGCAGT-GGACTC-3Ј). The resulting product was purified and cloned into EcoRI-digested pMT3A, which contains the SV40 origin and expresses the cloned gene from the adenovirus major late promoter (26) . MC013L mutants were constructed using pMT3A-MC013L DNA, mutagenic oligonucleotides (L122A, 5Ј-GCCGCGGACAC-GACGCCGAGACGCTCTTGG-3Ј; L125A,5Ј-GACCTC-GAGACGGCCTTGGATCTGTCGTCGCTCG-3Ј; L126A, 5Ј-GACCTCGAGACGCTCGCGGATCTGTCGCTCG-3Ј; and L125/126A, 5Ј-GACCTCGAGACGGCCGCGGATCTGTC-GCTCG-3Ј), and the GeneEditor site-directed mutagenesis system (Promega Corporation, WI).
Functional Assays. COS-7 cells were transfected by the calcium phosphate (Figs. 3a and 3b) or liposome (Fugene 6; Roche Molecular Biochemicals, Indianapolis, IN) (Fig. 2c ) methods with 10-20 ng of pSG5-VDR 1-427 (27), 2-2.5 g of VDRE 4 -TATA-GH (28), and increasing amounts of pMT3A-MC013L, made up to 1 g with empty vector. Other nuclear receptor/reporter plasmid pairs (pSG5-GR 1-783 /GRE 2 -TK-GH; pSG-ER 1-595 /ERE 2 -TATA-GH, and pSG-RAR 1-391 /RARE 4 -TATA-GH) (16) were similarly tested. Stripped sera were used in certain experiments. Sixteen hours after transfection, the monolayers were washed and treated with ethanol vehicle or the relevant ligand (VDR, 10 nM 1,25-(OH) 2 D 3 ; GR, 1 M dexamethasone; ER, 10 nM ␤-estradiol; RAR, 10 nM alltrans-retinoic acid). GH secreted into the media was quantitated 24 h following ligand addition using an immunoassay kit (Nichols Institute, San Juan Capistrano, CA). The results represent the means ϮSD of duplicate determinations.
Western Blot Assay. Cell monolayers were solubilized in SDS sample buffer and resolved in 12% polyacrylamide gels, and then separated proteins were transferred onto PVDF membrane. Blocked membranes were incubated for 1 h with primary antibody (1:2500 dilution of polyclonal anti-MC013L rabbit serum or 1:100 dilution of rat monoclonal antibody 947␥ against VDR) followed by an additional 1-h incubation with the second antibody [MC013L, 1:50,000 dilution of polyclonal goat anti-rabbit, and VDR, 1:8000 dilution of polyclonal goat anti-rat (Kirkegaard and Perry Laboratories, MD)]. The blots were developed with the ECL system (Amersham, IL).
Yeast Two-Hybrid Assays. All two-hybrid plasmid constructs used pAS1 or pGBT9 (bait) and the pGAD.GH (prey) vectors (29) . pAS1 contained a nuclear localization sequence preceding the DNA-binding domain of Gal4 , which was fused in frame to the ligand-binding domains of huVDR , RAR 143-391 , muGR 513-783 , or huER 263-595 or p53. Also, the complete ORFs for snf4 and G␣ were cloned into pAS1 as specificity controls. The MC013L WT and MC013L mutated genes were cloned as in frame fusions with the nuclear-targeted activation domain of Gal4 786-881 . Plasmids pGAD424.GRIP1/f1 and pGBT9-muGR 513-783 were constructed as described previously (30, 31) . The pGAD.GH WT and mutant MC013L plasmids were co-transformed with pAS1 derivatives into yeast strain SFY526 and incubated for 3 days at 30°C on leucine-and tryptophan-deficient plates containing ligand. After 3 days at 30°C, triplicate colonies were picked and cultured overnight in SC-selective liquid culture media containing ligand. Cells were assayed for ␤-galactosidase activity as described (32) .
GST Fusion Proteins and the in Vitro Protein Binding
Assay. The ligand-binding domains of huVDR , muGR , and huER 263-595 were inserted into the pGEX-KT expression vector (Pharmacia Biotech Inc., Piscataway, NJ). The GST fusion proteins were expressed and purified by glutathione-agarose affinity chromatography.
35 S-labeled MC013L was generated using the TNT-coupled transcription-translation system (Promega, Madison, WI) and reacted with 5 g of GST, GST-VDR, GST-GR, or GST-ER previously bound (in the presence or absence of appropriate ligand) to glutathione-agarose as described (16) . Eluted proteins were resolved by 10% SDS-PAGE and visualized by autoradiography, and band intensity was quantified by Phosphorimagery analysis.
Far Western Blot. The assay was carried out as described previously (16) . Briefly, GST fusion proteins were subjected to SDS-PAGE and electrophoretically transferred to PVDF membranes followed by a denaturation and renaturation cycle. The renatured blots were incubated overnight at 4°C in H buffer (20 mM HEPES, pH 7.7, 75 mM KCl, 0.1 mM EDTA, 2.5 mM MgCl 2 , 0.05% NP-40, 1% nonfat dried milk, and 1 mM DTT) containing a 32 Plabeled WT or L125/126A GST-MC013L probe (ϳ500,000 cpm/ml), but no ligand. After three washes in H buffer, the protein blots were subjected to autoradiography for ϳ3 h at RT.
Immunofluorescence. pMT3A-MC013L was transfected into slide cultures of COS-7 cells, and 48 h later the cells were fixed with 4% paraformaldehyde in PBS at 4°C for 10 min. The cells were permeabilized at Ϫ20°C with methanol containing 0.5 g/ml DAPI for 6 min and washed twice with methanol alone. Cells were rehydrated in PBS and treated first with a 1:2500 dilution of a rabbit polyclonal antibody against bacterially expressed His-tagged MC013L (pRSET C vector; Invitrogen, San Diego, CA), followed by goat anti-rabbit immunoglobulin G conjugated to fluorescein isothiocyanate (Organon Teknika, PA). Photographs were taken on Kodak T-Max 400 film using a Nikon epifluorescence microscope equipped with a 60ϫ Plan apo objective lens.
Immunocytochemistry on Formalin Fixed and Wax Embedded Molluscum Contagiosum Specimens.
The tissues were reacted for 30 min at ambient temperature with a 1:500 dilution of polyclonal rabbit antibody against MC013L. Bound antibody was detected with a 1:200 dilution of biotinylated goat anti-rabbit antibody in an ABC-horseradish peroxidase developing system using 3,3Ј-diaminobenzidine as the substrate and following the company's directions (Vector Laboratories, Inc., Burlingame, CA). The tissue sections were counter-stained with hematoxylin, washed, coated in crystal mount, and coverslipped with permount.
